Sisse Helle Njor (Sisse H Njor, Sisse Njor)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Venues

Breast cancer research and treatment

BMC women's health

International journal of cancer

Cancer medicine

Aarhus Universitet

University of Copenhagen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aarhus Universitet Jul 01 2018

Denmark

Associate Professor :: Institute of Clinical Medicine

Aarhus Universitet Jun 01 2015 - Mar 31 2017

Denmark

associate professor :: Department of clinical epidemiology

Aarhus Universitetshospital Jan 01 2015 - May 31 2015

Denmark

biostatistician :: Department of clinical epidemiology

University of Copenhagen Dec 09 2004 - Dec 31 2014

Denmark

post doc :: Center for epidemiology and screenng

Education History

University of Copenhagen Jan 01 2004 - Dec 08 2009

Denmark

PHD :: Department of public health

Publications

Susanne Fogh Jørgensen, Silje Sagstad, Javier Louro, Marta Román, Xavier Castells, Solveig Hofvind, Sisse Helle Njor
Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain. Breast cancer research and treatment 205 (1) (2024)
Susanne Fogh Jørgensen, Silje Sagstad, Javier Louro, Marta Román, Xavier Castells, Solveig Hofvind, Sisse Helle Njor
Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain. Breast cancer research and treatment 205 (1) (2024)
Anne Dorte Lerche Espersen, Mette Bach Larsen, Sisse Helle Njor, Mette Tranberg, Lone Kjeld Petersen, Berit Andersen
Increasing coverage in cervical and colorectal cancer screening by leveraging attendance at breast cancer screening: A cluster-randomised, crossover trial. PLoS medicine 21 (8) (2024)
Anne Dorte Lerche Espersen, Mette Bach Larsen, Sisse Helle Njor, Mette Tranberg, Lone Kjeld Petersen, Berit Andersen
Increasing coverage in cervical and colorectal cancer screening by leveraging attendance at breast cancer screening: A cluster-randomised, crossover trial. PLoS medicine 21 (8) (2024)
Pernille Thordal Larsen, Susanne Fogh Jørgensen, Rikke Hagemann-Madsen, Morten Rasmussen, Berit Andersen, Sisse Helle Njor
Detection of colorectal cancer and advanced neoplasia during first surveillance interval after detection of adenomas in fecal immunochemical test cancer screening: a nationwide study. Endoscopy (2024)
Susanne Fogh Jørgensen, Silje Sagstad, Javier Louro, Marta Román, Xavier Castells, Solveig Hofvind, Sisse Helle Njor
Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain. Breast cancer research and treatment (2024)
Susanne Fogh Jørgensen, Silje Sagstad, Javier Louro, Marta Román, Xavier Castells, Solveig Hofvind, Sisse Helle Njor
Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain. Breast cancer research and treatment 205 (1) (2024)
Susanne Fogh Jørgensen, Silje Sagstad, Javier Louro, Marta Román, Xavier Castells, Solveig Hofvind, Sisse Helle Njor
Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain. Breast cancer research and treatment 205 (1) (2024)
Jannie Villekjær Solnæs, Sisse Helle Njor, Mette Tranberg
Does full HPV genotyping perform similarly well in clinician-collected cervical samples and self-collected vaginal samples when using the CLART HPV4S assay? BMC women's health 23 (1) (2023)
Bayan Sardini, Susanne Fogh Jørgensen, Lisbet Brønsro Larsen, Mohammad Talal Elhakim, Sisse Helle Njor
Choice of Assessment and Subsequent Risk of Breast Cancer among Women with False-Positive Mammography Screening. Cancers 15 (6) (2023)
Jannie Villekjær Solnæs, Sisse Helle Njor, Mette Tranberg
Does full HPV genotyping perform similarly well in clinician-collected cervical samples and self-collected vaginal samples when using the CLART HPV4S assay? BMC women's health 23 (1) (2023)
Jannie Villekjær Solnæs, Sisse Helle Njor, Mette Tranberg
Does full HPV genotyping perform similarly well in clinician-collected cervical samples and self-collected vaginal samples when using the CLART HPV4S assay? BMC women's health 23 (1) (2023)
Tytti Sarkeala, Maarit Lamminmäki, Mari Nygård, Sisse Helle Njor, Anni Virtanen, Aku Leivonen, Elli Hirvonen, Salla Toikkanen, Suzanne Campbell, Hrefna Stefansdóttir, Giske Ursin, Sirpa Heinävaara
Cervical, liver and stomach cancer incidence and mortality in non-Western immigrant women: a retrospective cohort study from four Nordic countries. Acta oncologica (Stockholm, Sweden) (2023)
Jannie Villekjær Solnæs, Sisse Helle Njor, Mette Tranberg
Does full HPV genotyping perform similarly well in clinician-collected cervical samples and self-collected vaginal samples when using the CLART HPV4S assay? BMC women's health 23 (1) (2023)
Tina Bech Olesen, Henry Jensen, Henrik Møller, Jens Winther Jensen, Berit Andersen, Ilse Vejborg, Sisse Helle Njor
Nation-wide mammography screening participation in Denmark during the COVID-19 pandemic: an observational study. eLife 12 (2023)
Bayan Sardini, Susanne Fogh Jørgensen, Lisbet Brønsro Larsen, Mohammad Talal Elhakim, Sisse Helle Njor
Choice of Assessment and Subsequent Risk of Breast Cancer among Women with False-Positive Mammography Screening. Cancers 15 (6) (2023)
Matejka Rebolj, Alexandra Sargent, Sisse Helle Njor, Kate Cuschieri
Widening the offer of human papillomavirus self-sampling to all women eligible for cervical screening: Make haste slowly. International journal of cancer (2022)
Sisse Helle Njor, Mette Bach Larsen, Bo Søborg, Berit Andersen
Colorectal cancer mortality after randomized implementation of FIT-based screening - a nationwide cohort study. Journal of medical screening 29 (4) (2022)
Pernille Thordal Larsen, Morten Rasmussen, Sisse Helle Njor
Data from the Nielsen et al. study does not support their suggestion. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2021)
Sisse Helle Njor, Berit Andersen, Lennart Friis-Hansen, Niels de Haas, Dorte Linnemann, Henrik Nørgaard, Ole Roikjaer, Bo Søndergaard, Morten Rasmussen
The optimal cut-off value in fit-based colorectal cancer screening: An observational study. Cancer medicine 10 (5) (2021)
Susanne Fogh Jørgensen, Berit Andersen, Lone Kjeld Petersen, Matejka Rebolj, Sisse Helle Njor
Adherence to follow-up after the exit cervical cancer screening test at age 60-64: A nationwide register-based study. Cancer medicine (2021)
Jean-Luc Bulliard, Anna-Belle Beau, Sisse Helle Njor, Wendy Yi-Ying Wu, Pietro Procopio, Carolyn Nickson, Neda Esmailzadeh Bruun-Rasmussen
Breast cancer screening and overdiagnosis. International journal of cancer (2021)
Susanne Fogh Jørgensen, Berit Andersen, Anders Lernevall, Matejka Rebolj, Sisse Helle Njor
Variations in pathways and resource use in follow-up after abnormal mammography screening: a nationwide register-based study. Breast cancer research and treatment 189 (2) (2021)
Sisse Helle Njor, Ilse Vejborg, Mette Bach Larsen
Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening. Cancer medicine 9 (16) (2020)
Sisse Helle Njor, Neda Esmailzadeh Bruun-Rasmussen
Loss of QALY in mammography screening reported by Zahl et al. International journal of cancer 146 (4) (2019)
Susanne Fogh Jørgensen, Sisse Helle Njor
Higher cervical cancer mortality among older women in Denmark could be due to insufficient screening coverage. Acta obstetricia et gynecologica Scandinavica 98 (11) (2019)
Sisse Helle Njor, Eugenio Paci, Matejka Rebolj
As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screening. International journal of cancer 143 (6) (2018)

Sisse Helle Njor.css-eqlu8i{font-size:small;padding-left:4px;} (Sisse H Njor, Sisse Njor)

Publication Activity (10 Years)

Top Topics

Top Venues

Sisse Helle Njor (Sisse H Njor, Sisse Njor)